AI in health: risks, AI Act compliance and GDPR challenges
The integration of AI in health imposes new compliance challenges related to the GDPR and the AI Act. While the ergonomics of the tools facilitate care, it should not lead to medical disempowerment. For DPOs and CISOs, the challenge is to guarantee effective human surveillance and data sovereignty in the face of legal and technical risks. Learn how to secure your AI deployments while respecting medical confidentiality.
Midday coffee sometimes reveals the evolution of uses. Recent experience with a new treatment protocol testifies to this: even before the consultation, completing a surgically accurate online questionnaire via a dedicated platform has become the norm. Questions so intrusive that they sometimes lend themselves to irony: “At this stage, I am almost waiting for my appointment to be cancelled before sending me the prescription directly by email! ”.
This anecdote illustrates a major civilizational shift. The daily observation of these systems reveals a systemic risk: that of disempowerment through digital comfort. This phenomenon recalls the excesses of Sharenting : this propensity to give up the most sensitive data for immediate benefit, without always measuring the extent of this abandonment of privacy in favor of the machine.
The integration ofAI in health is not limited to a simple technical innovation. While it promises a better qualification of symptoms and support for isolated territories, it imposes new challenges of conformity related to RGPD and at theIA Act. Between fluidity biases and the imperatives of human surveillance, the DPO and data professionals must navigate between immediate benefits and the long-term protection of medical privacy.
The benefits of AI in health: a response to the healthcare crisis
It would be simplistic to see these tools only as a threat. The multiplication of these uses responds to a profound crisis in our healthcare system. AI, when integrated ethically, brings concrete benefits:
- Better qualification: it ensures that no symptoms are omitted in the stress of the consultation and allows the patient to prepare his history calmly
- Identifying weak signals: algorithms excel in identifying complex correlations that could escape a practitioner at the end of their guard
- Maintaining the medical link: in isolated territories, teleconsultation booths and pre-reception terminals are sometimes the last ramparts against giving up on care
The challenge is therefore not to reject innovation, but to understand when ergonomics begins to mask risk.
The fluidity bias: the risks of collecting health data
We are witnessing a shift from clinical examination to a user experience (UX) so perfectly oiled that it becomes anesthetic. This is where the tipping point is: the fluidity bias. Making the data collection process “seamless” eliminates the cognitive friction needed to make decisions.
The patient, driven by the ease of the interface, transmits highly sensitive biometric information with a lightness that he would never have had in the face of a direct human interview. Fluidity becomes a smokescreen: because the process is fast and intuitive, we end up forgetting the critical dimension of the act. Convenience trumps risk awareness.
Medical efficiency vs performance: the impact of AI on medical time
AI promises to free up medical time by delegating administrative brush cutting. However, Health Insurance figures show that doctors supported by automated tools or assistants are recording an increase in their patients. by nearly 20%.
The trap is structural: if this saving of time is systematically reinvested to increase the pace and absorb flows, AI no longer serves healthcare, but becomes a driver of industrial efficiency. The risk is to see care go from a singular conference to an assembly line where the algorithm plays the role of foreman. The doctor then risks losing control of the long term, which is essential to diagnostic quality.
Legal responsibility and compliance with the IA Act in the medical sector
Legally, the act of technical validation — this famous green button — makes an irreversible switch: it transforms a simple statistical probability produced by a machine into a sovereign medical decision. It is not a simple administrative formality, it is the meeting point between the law of evidence and ethics.
Medical independence and ethics in the face of algorithms
According to the Public Health Code (Art. R4127-40), the physician must exercise his mission independently. Following an algorithm blindly is not a decision aid, it is an abandonment of this independence. For the judge, AI remains a support tool and not an expert. By validating a suggestion, the practitioner assumes all the consequences of a possible hallucination or error by the AI.
Human surveillance obligations and due diligence under the AI Act
Since August 2024, the European regulation on AI (IA Act) classifies health as a high-risk sector. This requires the professional to human surveillance (human oversight). It's no longer just about not making mistakes, it's about showing that you've stayed in control. The click on the green button without a clinical second opinion could be qualified as a fault characterized by a lack of vigilance.
Civil liability and loss of opportunity due to the AI error
If the AI omits a vital diagnosis and the doctor validates this omission with a quick click, the causal link between the lack of verification and the patient's loss of chance becomes direct. The ease of the interface never constitutes an extenuating circumstance before a court; it is indicative of a breach of the obligation of means.
Digital sovereignty: Cloud Act, HDS label and medical secrecy
Trust cannot be limited to superficial compliance. The label HDS (Health Data Host) is an essential technical guarantee, but it does not guarantee sovereignty.
Stored data is not protected data if the infrastructure belongs to an actor subject to extraterritorial legislation such as Cloud Act. Real protection requires infrastructures under strictly European law. Without legal sovereignty, medical confidentiality becomes a fragile promise, regardless of the immediate benefit provided by the tool.
Conclusion: reintroducing vigilance in the use of AI in health
The evolution towards increased health is an opportunity, but it requires us to leave the hypnosis of fluidity. We need to reintroduce friction where it is needed: in consent, in thinking, and in human expertise.
Technology is a magnificent tool as long as it remains a precision instrument; it becomes a dehumanizing filter as soon as it dictates the career-patient relationship. Let's not treat our health data as lightly as we treat the image of our children online. The protection of our medical privacy is the great challenge of our digital century: efficiency should never be paid at the price of our discernment.
FAQ - AI in health and AI Act compliance
What are the risks of AI in health for data protection?
The main risk lies in the fluidity bias, where the ergonomics of the interfaces push patients to share sensitive biometric data without full awareness of the challenges. Compliance RGPD However, it requires clear information and informed consent.
How does the AI Act frame the use of AI in the medical sector?
Since August 2024, theIA Act classifies health as a high-risk sector. This requires a human surveillance (human oversight) constant. The professional must demonstrate that he maintains control over the tool and does not blindly validate the algorithm's suggestions.
Is the HDS label sufficient to guarantee the sovereignty of health data?
No, the HDS label provides technical security but not legal sovereignty. If the host is subject to extraterritorial laws such as Cloud Act, medical confidentiality may be compromised. Real protection requires infrastructures under strictly European law.
